Cargando…
Bistable insulin response: The win-win solution for glycemic control
To satisfy both the safety and rapidity of glycemic control, muscles’ insulin response must be bistable, as theoretically predicted. Here, we test the bistability hypothesis by combining cellular experiments (to measure the threshold values in vitro) with mathematical modeling (to test the relevance...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708922/ https://www.ncbi.nlm.nih.gov/pubmed/36465102 http://dx.doi.org/10.1016/j.isci.2022.105561 |
_version_ | 1784841047821516800 |
---|---|
author | Akhtar, Javed Han, Yukun Han, Shangchen Lin, Weiping Cao, Chenyu Ge, Ruowen Babarinde, Isaac Adeyemi Jia, Qingzhao Yuan, Yueyang Chen, Guangming Zhao, Yajie Ye, Richard Liu, Guozhen Chen, Luonan Wang, Guanyu |
author_facet | Akhtar, Javed Han, Yukun Han, Shangchen Lin, Weiping Cao, Chenyu Ge, Ruowen Babarinde, Isaac Adeyemi Jia, Qingzhao Yuan, Yueyang Chen, Guangming Zhao, Yajie Ye, Richard Liu, Guozhen Chen, Luonan Wang, Guanyu |
author_sort | Akhtar, Javed |
collection | PubMed |
description | To satisfy both the safety and rapidity of glycemic control, muscles’ insulin response must be bistable, as theoretically predicted. Here, we test the bistability hypothesis by combining cellular experiments (to measure the threshold values in vitro) with mathematical modeling (to test the relevance of bistability in vivo). We examine bistability in C2C12 myotubes by both single-cell analysis (Fӧrster resonance energy transfer) and cultured cells analysis (immunoblot). These technologies demonstrate bistable insulin response, with typical switch-on and switch-off thresholds of approximately 300 and 100 pM, respectively. Our mathematical model demonstrates the indispensability of bistability in interpreting experimental data, reveals fine details of plasma glucose-insulin dynamics, and explains unclear phenomena. These results suggest that the body’s ability to simultaneously avoid both hypoglycemia and hyperglycemia is mediated by bistability. The switch-on threshold is a promising biomarker for metabolic complications due to its deep quantitative connection with body composition, which is easy to measure. |
format | Online Article Text |
id | pubmed-9708922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-97089222022-12-01 Bistable insulin response: The win-win solution for glycemic control Akhtar, Javed Han, Yukun Han, Shangchen Lin, Weiping Cao, Chenyu Ge, Ruowen Babarinde, Isaac Adeyemi Jia, Qingzhao Yuan, Yueyang Chen, Guangming Zhao, Yajie Ye, Richard Liu, Guozhen Chen, Luonan Wang, Guanyu iScience Article To satisfy both the safety and rapidity of glycemic control, muscles’ insulin response must be bistable, as theoretically predicted. Here, we test the bistability hypothesis by combining cellular experiments (to measure the threshold values in vitro) with mathematical modeling (to test the relevance of bistability in vivo). We examine bistability in C2C12 myotubes by both single-cell analysis (Fӧrster resonance energy transfer) and cultured cells analysis (immunoblot). These technologies demonstrate bistable insulin response, with typical switch-on and switch-off thresholds of approximately 300 and 100 pM, respectively. Our mathematical model demonstrates the indispensability of bistability in interpreting experimental data, reveals fine details of plasma glucose-insulin dynamics, and explains unclear phenomena. These results suggest that the body’s ability to simultaneously avoid both hypoglycemia and hyperglycemia is mediated by bistability. The switch-on threshold is a promising biomarker for metabolic complications due to its deep quantitative connection with body composition, which is easy to measure. Elsevier 2022-11-13 /pmc/articles/PMC9708922/ /pubmed/36465102 http://dx.doi.org/10.1016/j.isci.2022.105561 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Akhtar, Javed Han, Yukun Han, Shangchen Lin, Weiping Cao, Chenyu Ge, Ruowen Babarinde, Isaac Adeyemi Jia, Qingzhao Yuan, Yueyang Chen, Guangming Zhao, Yajie Ye, Richard Liu, Guozhen Chen, Luonan Wang, Guanyu Bistable insulin response: The win-win solution for glycemic control |
title | Bistable insulin response: The win-win solution for glycemic control |
title_full | Bistable insulin response: The win-win solution for glycemic control |
title_fullStr | Bistable insulin response: The win-win solution for glycemic control |
title_full_unstemmed | Bistable insulin response: The win-win solution for glycemic control |
title_short | Bistable insulin response: The win-win solution for glycemic control |
title_sort | bistable insulin response: the win-win solution for glycemic control |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708922/ https://www.ncbi.nlm.nih.gov/pubmed/36465102 http://dx.doi.org/10.1016/j.isci.2022.105561 |
work_keys_str_mv | AT akhtarjaved bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT hanyukun bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT hanshangchen bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT linweiping bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT caochenyu bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT geruowen bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT babarindeisaacadeyemi bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT jiaqingzhao bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT yuanyueyang bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT chenguangming bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT zhaoyajie bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT yerichard bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT liuguozhen bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT chenluonan bistableinsulinresponsethewinwinsolutionforglycemiccontrol AT wangguanyu bistableinsulinresponsethewinwinsolutionforglycemiccontrol |